IL-35 over-expression is associated with genesis of gastric cancer

Asian Pacific Journal of Cancer Prevention

Volumn 16, Issue 7, 2015, Pages 2845-2849

  Fan, Yong Gang ^a   Zhai, Jing Ming ^a   Wang, Wei ^a   Feng, Bing ^a   Yao, Guo Liang ^a   An, Yan Hui ^a   Zeng, Chao ^b  

^a HENAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b GUANGDONG MEDICAL UNIVERSITY   (China)

Author keywords

Bcl 2; Gastric cancer; IL 35; Ki 67

Indexed keywords

INTERLEUKIN DERIVATIVE; INTERLEUKIN-35, HUMAN; TUMOR MARKER;

AGED; APOPTOSIS; CANCER GRADING; CANCER STAGING; CELL PROLIFERATION; ENZYME IMMUNOASSAY; FEMALE; FOLLOW UP; HUMAN; LYMPH NODE METASTASIS; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; PROGNOSIS; STOMACH TUMOR; TISSUE MICROARRAY; TUMOR CELL CULTURE; TUMOR INVASION;

AGED; APOPTOSIS; BIOMARKERS, TUMOR; CELL PROLIFERATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOENZYME TECHNIQUES; INTERLEUKINS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PROGNOSIS; STOMACH NEOPLASMS; TISSUE ARRAY ANALYSIS; TUMOR CELLS, CULTURED;

EID: 84928594961     PISSN: 15137368     EISSN: None     Source Type: Journal    
DOI: 10.7314/APJCP.2015.16.7.2845     Document Type: Article

References (18)

1. Collison LW, Workman CJ, Kuo TT, et al (2007). The inhibitory cytokine IL-35 contributes to regulatory T-cell function. Nature, 450, 566-9.
2. Collison LW, Chaturvedi V, Henderson AL, et al (2010). IL-35-mediated induction of a potent regulatory T cell population. Nat Immunol, 11, 1093-101.
3. Devergne O, Birkenbach M, Kieff E (1997). Epstein-Barr virus-induced gene 3 and the p35 subunit of interleukin 12 form a novel heterodimeric hematopoietin. Proc Natl Acad Sci USA, 94, 12041-6.
4. Huang CH, Loo EX, Kuo IC, et al (2011). Airway inflammation and IgE production induced by dust mite allergen-specific memory/effector Th2 cell line can be effectively attenuated by IL-35. J Immunol, 187, 462-71.
5. Kochetkova I, Golden S, Holderness K, et al (2010). IL-35 stimulation of CD39+ regulatory T cells confers protection against collagen II-induced arthritis via the production of IL-10. Immunol, 184, 7144-53.
6. Larousserie F, Bardel E, Pflanz S, et al (2005). Analysis of interleukin-27 (EBI3/p28) expression in Epstein-Barr virus-and human T-cell leukemia virus type 1-associated lymphomas: heterogeneous expression of EBI3 subunit by tumoral cells. Am J Pathol, 166, 1217-28.
7. Li X, Mai J, Virtue A, et al (2012). IL-35 is a novel responsive anti-inflammatory cytokine-a new system of categorizing anti-inflammatory cytokines. PLoS One, 7, 33628.
8. Long J, Zhang X, Wen M, et al (2013). IL-35 over-expression increases apoptosis sensitivity and suppresses cell growth in human cancer cells. Biochem Biophys Res Commun, 430, 364-9.
9. Niedobitek G, Pazolt D, Teichmann M, et al (2002). Frequent expression of the Epstein-Barr virus (EBV)-induced gene, EBI3, an IL-12 p40-related cytokine, in Hodgkin and Reed-Sternberg cells. J Pathol, 198, 310-6.
10. Niedbala W, Wei XQ, Cai B, et al (2007). IL-35 is a novel cytokine with therapeutic effects against collagen-induced arthritis through the expansion of regulatory T cells and suppression of Th17 cells. Eur J Immunol, 37, 3021-9.
11. Nishino R, Takano A, Oshita H, et al (2011). Identification of Epstein-Barr virus-induced gene 3 as a novel serum and tissue biomarker and a therapeutic target for lung cancer. Clin Cancer Res, 17, 6272-86.
12. Pflanz S, Timans JC, Cheung J, et al (2002). IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4 (+) T cells. Immunity, 16, 779-90.
13. Poleganov MA, Bachmann M, Pfeilschifter J, et al (2008). Genome-wide analysis displays marked induction of EBI3/IL-27B in IL-18-activated AML-derived KG1 cells: critical role of two kappaB binding sites in the human EBI3 promotor. Mol Immunol, 45, 2869-80.
14. Schrader JW (2002). Interleukin is as interleukin does. Trends Immunol, 23, 573-4.
15. Seyerl M, Kirchberger S, Majdic O, et al (2010). Human rhinoviruses induce IL-35-producing Treg via induction of B7-H1 (CD274) and sialoadhesin (CD169) on DC. Eur J Immunol, 40, 321-9.
16. Wang Z, Liu JQ, Liu Z, et al (2013). Tumor-derived IL-35 promotes tumor growth by enhancing myeloid cell accumulation and angiogenesis. J Immunol, 190, 2415-23.
17. Whitehead GS, Wilson RH, Nakano K, et al (2012). IL-35 production by inducible costimulator (ICOS)-positive regulatory T cells reverses established IL-17-dependent allergic airways disease. J Allergy Clin Immunol, 129, 207-15.
18. Zeng JC1, Zhang Z, Li TY, et al (2013). Assessing the role of IL-35 in colorectal cancer progression and prognosis. Int J Clin Exp Pathol, 6, 1806-16.